DK542781A - Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf - Google Patents

Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf

Info

Publication number
DK542781A
DK542781A DK542781A DK542781A DK542781A DK 542781 A DK542781 A DK 542781A DK 542781 A DK542781 A DK 542781A DK 542781 A DK542781 A DK 542781A DK 542781 A DK542781 A DK 542781A
Authority
DK
Denmark
Prior art keywords
cytosin
tricyclic
procedures
derivatives
production
Prior art date
Application number
DK542781A
Other languages
English (en)
Inventor
B Junge
S Goldmann
G Thomas
B Garthoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK542781A publication Critical patent/DK542781A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK542781A 1980-12-09 1981-12-08 Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf DK542781A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803046366 DE3046366A1 (de) 1980-12-09 1980-12-09 Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DK542781A true DK542781A (da) 1982-06-10

Family

ID=6118700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK542781A DK542781A (da) 1980-12-09 1981-12-08 Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf

Country Status (13)

Country Link
US (1) US4585772A (da)
EP (1) EP0053767B1 (da)
JP (1) JPS57122085A (da)
AT (1) ATE9350T1 (da)
AU (1) AU549240B2 (da)
CA (1) CA1184910A (da)
DE (2) DE3046366A1 (da)
DK (1) DK542781A (da)
ES (2) ES507807A0 (da)
FI (1) FI813912L (da)
HU (1) HU191038B (da)
IL (1) IL64472A0 (da)
ZA (1) ZA818499B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4831013A (en) * 1986-03-20 1989-05-16 Ciba-Geigy Corporation 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof
FR2659329B1 (fr) * 1990-03-09 1994-06-03 Adir Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5158953A (en) * 1991-08-13 1992-10-27 National Science Council 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
US5539260A (en) * 1994-08-29 1996-07-23 Ford Motor Company Method and apparatus for an automotive security system which permits engine running prior to code comparison
US5637929A (en) * 1996-01-16 1997-06-10 Ford Motor Company Method and apparatus for enhanced vehicle protection
US7375125B2 (en) * 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
JP2003528810A (ja) * 1999-08-04 2003-09-30 ミレニアム ファーマスーティカルズ インク メラノコルチン−4受容体結合化合物及びその使用方法
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
WO2013177053A1 (en) * 2012-05-21 2013-11-28 Allergan, Inc. Pyrimidino [1, 2 -c] quinazolinone derivatives as tyrosine kinases inhibitors
BR112014031730B1 (pt) 2012-06-18 2023-05-16 Dart Neuroscience (Cayman) Ltd Compostos ou sais farmaceuticamente aceitáveis dos mesmos e seu uso
JP6420400B2 (ja) * 2017-04-12 2018-11-07 ダート・ニューロサイエンス・(ケイマン)・リミテッド 置換ピリジンアゾロピリミジン−5−(6h)−オン化合物
CN108178759B (zh) * 2018-01-05 2020-06-09 上海瑞纷医药科技有限责任公司 一种α-肾上腺素受体拮抗剂的合成方法
GB2575490A (en) * 2018-07-12 2020-01-15 Recordati Ind Chimica E Farmaceutica Spa P2X3 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
CA986932A (en) * 1970-08-27 1976-04-06 Shigeho Inaba Process for preparing quinazoline derivatives
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI813912L (fi) 1982-06-10
CA1184910A (en) 1985-04-02
ATE9350T1 (de) 1984-09-15
DE3166084D1 (en) 1984-10-18
ES507810A0 (es) 1983-10-16
ES8300111A1 (es) 1982-10-01
AU549240B2 (en) 1986-01-23
AU7831781A (en) 1982-06-17
EP0053767A1 (de) 1982-06-16
DE3046366A1 (de) 1982-07-08
JPS57122085A (en) 1982-07-29
IL64472A0 (en) 1982-03-31
ZA818499B (en) 1982-11-24
EP0053767B1 (de) 1984-09-12
ES8400076A1 (es) 1983-10-16
US4585772A (en) 1986-04-29
HU191038B (en) 1986-12-28
ES507807A0 (es) 1982-10-01

Similar Documents

Publication Publication Date Title
IL58775A0 (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
IL58782A (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
DK542781A (da) Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
DE3064109D1 (en) Pseudotrisaccharides, their preparation and use as medicaments
IL59768A (en) Prostaglandin derivatives of the 6-keto-pge1 series,process for their preparation and pharmaceutical compositions containing them
IL58774A (en) Fluorenyl-azolylmethylcarbinol compounds,their production and pharmaceutical compositions containing them
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
DE2960583D1 (en) Novel 2-substituted-3-heterocyclylindoles, their preparation and pharmaceutical compositions containing them
EP0036991B1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
DK239084A (da) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitriler

Legal Events

Date Code Title Description
ATS Application withdrawn